Bristol Myers Squibb

U.S. pharma major with a broad oncology and immunology portfolio.

Coverage of Bristol Myers Squibb is newly on the wire •: 4 signals on the latest tracked day, level with its three-week baseline of 4, across 3 domains. That makes it the #94 most-covered of the 126 concerns we track.

If Bristol Myers Squibb matters to your work, it just crossed our flagging thresholds — early and thin history, so watch whether the next few days confirm the move or fade it.